Thomas Stanton
Hematology & Oncology · Petaluma, CANPI 1699855445
Payments from drug & device makers
Across 295 payments — averaging $2167.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$187K
- AstraZeneca$125K
- Clovis Oncology, Inc.$103K
- Roche Products Limited$76K
- Pfizer$69K
- Pharmacyclics LLC, An Abbvie Company$17K
- plus $62K from 23 others
Across 12 payments — averaging $219.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$1K
- Pfizer$1K
What the payments were for
- Consulting fees$5,00376%
- Travel & lodging$5118%
- Food & beverage$1,07216%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 58 | $186,778 |
| AstraZeneca(2 entities) | 20 | $124,694 |
| Clovis Oncology, Inc. | 64 | $103,084 |
| Roche Products Limited | 32 | $76,336 |
| Pfizer | 7 | $68,935 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $17,350 |
| GSK | 7 | $17,014 |
| Incyte Corporation | 48 | $14,273 |
| Merck | 10 | $11,669 |
| E.r. Squibb & Sons, L.L.C. | 8 | $9,871 |
| Bristol Myers Squibb | 9 | $7,451 |
| Ipsen Biopharmaceuticals, Inc | 2 | $1,440 |
| Bayer | 3 | $68 |
| Genentech USA, Inc. | 3 | $67 |
| Seagen Inc. | 3 | $55 |
| Rigel Pharmaceuticals, Inc. | 2 | $47 |
| Amgen | 2 | $40 |
| Novartis | 2 | $39 |
| Agios Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| Eisai Inc. | 1 | $24 |
| Taiho Oncology, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Dendreon Pharmaceuticals LLC | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reblozyl$4,104
- ONIVYDE$1,080
- SOMATULINE DEPOT$360
How this compares
$639,449 in reported general payments places this provider in the 85th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Petaluma
- Alain AlgaziSan Francisco$119.2M
- David BerzLos Angeles$43.3M
- Jonathan GoldmanSanta Monica$35.7M
- Omid HamidSanta Monica$23.7M
- Nicholas McAndrewLos Angeles$22.9M
- Aditya BardiaSanta Monica$22.1M
- Joseph TuscanoSacramento$20.4M
- Zev WainbergSanta Monica$19.3M
- Caitlin CostelloSan Diego$16.9M
- Rana McKaySan Diego$15.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.